-
ATRX mutant neuroblastoma is sensitive to EZH2 inhibition via modulation of neuronal differentiation.
Study
EGAS00001002507
-
Cell motility and migration as determinants of stem cell efficacy
Study
EGAS00001002478
-
Mutational signatures of aflatoxin
Study
EGAS00001002490
-
Sampling of multi-centric lower grade glioma influences management and provides insight into gliomagenesis
Study
EGAS00001002495
-
Genome-wide expression profiles to compare array-based, RNAseq and NanoString technologies in patients with resected pancreatic ductal carcinoma.
Study
EGAS00001002501
-
Transcriptome sequencing of intravenous leiomyomatosis and uterine myoma
Study
EGAS00001002504
-
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
Study
EGAS00001002538
-
Exome-wide somatic mutation characterization of small bowel adenocarcinoma
Study
EGAS00001002559
-
Exome sequencing data from two myelosarcomas
Study
EGAS00001002562
-
Pilot study for Illumina TST170 NGS panel on cutaneous T cell lymphoma samples
Study
EGAS00001002567
-
The genomic landscape of cutaneous squamous cell carcinoma from immunosuppressed and immunocompetent patients reveals common drivers and a novel mutational signature associated with chronic azathioprine exposure
Study
EGAS00001002612
-
Whole-exome sequencing of ovarian clear cell carcinoma in clinical outliers
Study
EGAS00001004248
-
We performed whole-exome sequencing of 20 samples (10 actinic keratosis and 10 cutaneous squamous cell carcinoma) to investigate a potential relationship between DNA methylation-based subtypes and genetic mutation patterns (Rodriguez-Paredes et al., Nat Commun 2017)
Study
EGAS00001002670
-
Alternative splicing isoforms in patient-derived hepatocellular carcinoma cells
Study
EGAS00001002697
-
Gut microbiome modulates response to anti PD1 immunotherapy in metastatic melanoma patients
Study
EGAS00001002698
-
Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma
Study
EGAS00001002705
-
Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.
Study
EGAS00001002707